Do you mean sales as in market size/revenue, or how lorazepam is sold (brands, generics, dosage forms), and for what region and timeframe?
A quick context:
- Lorazepam (brand name Ativan in the U.S., with many generics available) is a benzodiazepine used for anxiety, sedation, seizures, and other indications.
- It is a Schedule IV controlled substance in the United States, so distribution and prescribing are tightly regulated.
- Because there are many manufacturers and both brand and generic versions, public, exact sales figures aren’t easy to pull from a simple source. Market research firms (IQVIA, EvaluatePharma, Statista, etc.) publish estimates that typically require a subscription.
- In the U.S., data on distribution of controlled substances is tracked (ARCOS) and can give you a sense of total domestic distribution, but it’s more of a supply-distribution metric than consumer sales.
If you can tell me:
- region (e.g., U.S., Europe, global),
- time period (e.g., last year, last 5 years),
- whether you want brand vs generic or both,
I can guide you to the right public sources and summarize the publicly available trends. I can also point you to official sources (like DEA ARCOS data for regulated substances) if you want raw numbers.